Nathan Bennett

1.9k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Nathan Bennett is a scholar working on Physiology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nathan Bennett has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 6 papers in Psychiatry and Mental health and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nathan Bennett's work include Migraine and Headache Studies (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Nathan Bennett is often cited by papers focused on Migraine and Headache Studies (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Nathan Bennett collaborates with scholars based in United States, Germany and United Kingdom. Nathan Bennett's co-authors include Melinda Gooderham, Mary Flack, J.‐P. Lacour, Alan Menter, Steven J. Padula, Howard Sofen, Kim Papp, Stephen K. Tyring, Sudha Visvanathan and B Berner and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Neurology.

In The Last Decade

Nathan Bennett

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

2017 392 citations Kim Papp, Andrew Blauvelt et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan Bennett United States	14	349	263	228	201	189	21	1.1k
P. Carpentier France	19	196 0.6×	95 0.4×	202 0.9×	162 0.8×	282 1.5×	71	1.5k
Tracy Frech United States	26	441 1.3×	142 0.5×	325 1.4×	81 0.4×	611 3.2×	115	2.0k
Winston Sequeira United States	18	238 0.7×	80 0.3×	146 0.6×	45 0.2×	127 0.7×	37	1.1k
María Pilar Cruz-Domínguez Mexico	16	214 0.6×	59 0.2×	142 0.6×	35 0.2×	126 0.7×	64	890
Charles F. Barish United States	18	190 0.5×	187 0.7×	225 1.0×	122 0.6×	12 0.1×	37	1.8k
Şükran Erten Türkiye	16	172 0.5×	141 0.5×	63 0.3×	36 0.2×	67 0.4×	108	887
Eva Klingberg Sweden	21	527 1.5×	67 0.3×	120 0.5×	37 0.2×	54 0.3×	60	1.6k
Scott F. Gallagher United States	22	70 0.2×	333 1.3×	153 0.7×	130 0.6×	67 0.4×	44	1.4k
Kelley E. Capocelli United States	21	263 0.8×	143 0.5×	204 0.9×	31 0.2×	13 0.1×	43	1.3k
Yarden Yavne Israel	12	172 0.5×	67 0.3×	276 1.2×	21 0.1×	26 0.1×	30	827

Countries citing papers authored by Nathan Bennett

Since Specialization

Citations

This map shows the geographic impact of Nathan Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Bennett more than expected).

Fields of papers citing papers by Nathan Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Bennett. The network helps show where Nathan Bennett may publish in the future.

Co-authorship network of co-authors of Nathan Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Bennett. A scholar is included among the top collaborators of Nathan Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Bennett. Nathan Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hutchinson, Susan, David W. Dodick, Nathan Bennett, et al.. (2021). Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials. Neurology and Therapy. 10(1). 235–249. 15 indexed citations

Schwedt, Todd J., Joseph G. Hentz, Soma Sahai‐Srivastava, et al.. (2021). Headache characteristics and burden from chronic migraine with medication overuse headache: Cross‐sectional observations from the Medication Overuse Treatment Strategy trial. Headache The Journal of Head and Face Pain. 61(2). 351–362. 31 indexed citations

Dodick, David W., Anand R. Shewale, Richard B. Lipton, et al.. (2020). Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data. Journal of Primary Care & Community Health. 11. 3373109344–3373109344. 46 indexed citations

Hutchinson, Susan, David W. Dodick, Nathan Bennett, et al.. (2020). Ubrogepant for the Acute Treatment of Migraine: Pooled Safety and Tolerability From ACHIEVE I and ACHIEVE II Phase 3 Studies (117). Neurology. 94(15_supplement). 2 indexed citations

Ning, Xiaoping, Joshua M. Cohen, Nathan Bennett, Paul Yeung, & Ronghua Yang. (2019). Long-Term Safety of Fremanezumab: Results of a 1-Year Study (P1.10-015). Neurology. 92(15_supplement). 3 indexed citations

Mitcheson, H. David, Suvajit Samanta, Cathy Anne Pinto, et al.. (2018). Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial. European Urology. 75(2). 274–282. 46 indexed citations

Papp, Kim, Andrew Blauvelt, Michael Bukhalo, et al.. (2017). Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis. New England Journal of Medicine. 376(16). 1551–1560. 392 indexed citations breakdown →

Ferguson, Gary T., Jill P. Karpel, Nathan Bennett, et al.. (2017). Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. npj Primary Care Respiratory Medicine. 27(1). 7–7. 22 indexed citations

Abrahams, R, Gary T. Ferguson, Emmanuelle Clerisme-Beaty, et al.. (2015). Effect of Tiotropium + Olodaterol on the Use of Nighttime Rescue Medication in Patients With COPD: Results From Four Randomized, Double-Blind Studies. CHEST Journal. 148(4). 731A–731A. 1 indexed citations

10.

Ferguson, Gary T., Emmanuelle Clerisme-Beaty, Florian Voß, et al.. (2015). Tiotropium + Olodaterol Provides Improvements in SGRQ and Dyspnea Compared With Monotherapy Components in Patients With COPD: Results From Four Randomized, Double-Blind Studies. CHEST Journal. 148(4). 726A–726A. 1 indexed citations

11.

Singh, Dave, Gary T. Ferguson, J Bolitschek, et al.. (2015). Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respiratory Medicine. 109(10). 1312–1319. 126 indexed citations

12.

Singh, Dave, Gary T. Ferguson, J Bolitschek, et al.. (2015). Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo. PA2958–PA2958. 5 indexed citations

13.

Thajudeen, Anees, Warren M. Jackman, Brian D. Stewart, et al.. (2015). Correlation of Scar in Cardiac MRI and High‐Resolution Contact Mapping of Left Ventricle in a Chronic Infarct Model. Pacing and Clinical Electrophysiology. 38(6). 663–674. 24 indexed citations

14.

Cokic, Ivan, Avinash Kali, Xunzhang Wang, et al.. (2013). Iron Deposition following Chronic Myocardial Infarction as a Substrate for Cardiac Electrical Anomalies: Initial Findings in a Canine Model. PLoS ONE. 8(9). e73193–e73193. 17 indexed citations

15.

Campbell, James D., Christopher V. Chambers, Rebecca C. Brady, et al.. (2011). Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine. Human Vaccines. 7(1). 81–88. 6 indexed citations

16.

Cady, Roger, Robert Nett, Jerome Goldstein, et al.. (2011). Multi‐Center Comparison of Response to a Single Tablet of Sumatriptan 85 mg and Naproxen 500 mg vs Usual Therapy Treating Multiple Migraine Attacks as Measured by the Completeness of Response Survey. Headache The Journal of Head and Face Pain. 51(6). 961–970. 6 indexed citations

17.

Collier, Scott R., Jill A. Kanaley, Robert Carhart, et al.. (2008). Cardiac autonomic function and baroreflex changes following 4 weeks of resistance versus aerobic training in individuals with pre‐hypertension. Acta Physiologica. 195(3). 339–348. 97 indexed citations

18.

Catassi, Carlo, Donald R. Duerksen, Suzanne M. Crowe, et al.. (2007). Detection of Celiac Disease in Primary Care: A Multicenter Case-Finding Study in North America. The American Journal of Gastroenterology. 102(7). 1454–1460. 184 indexed citations

19.

Jones, Rebecca, et al.. (1985). Thermoregulation during aerobic exercise in pregnancy.. PubMed. 65(3). 340–5. 50 indexed citations

20.

Chez, Ronald A., et al.. (1984). Variations of biologic activity of low-dose prostaglandin E2 on cervical ripening.. PubMed. 64(1). 123–7. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact